Precision means a strain, a dose, and a reason.
We name what’s in the bottle. We disclose the dose. We tie every claim to a published mechanism. That’s the floor — not the ceiling.
An unparalleled collaboration between microbiology, clinical research, and translational science.
Dr. Gauguier is a leading expert in metabolic disease genetics and a pioneer in the discovery of 4-Cresol's therapeutic potential. He is Director of Research at INSERM (Université Paris–Cité), and holds visiting and adjunct positions at Imperial College London, Kyoto University, and McGill University.
He earned his Ph.D. in human nutrition in Paris and previously served as Professor of mammalian genetics at Oxford University.
Dr. Matsuda has extensive experience in genomics and headed the Centre National de Génotypage. He held a double appointment as Professor at Kyoto University and Directeur de Recherche of INSERM.
He is a Knight of the National Order of Merit and a Chevalier de l'Ordre des Palmes Académiques. He earned his Ph.D. from the Kyoto University Graduate School of Medicine.
Dr. Wood is a distinguished expert in clinical pharmacology with extensive leadership in biotech and pharmaceutical companies. He is Executive Vice-President for Nuvoselex Network (U.S.), overseeing U.S. operations and services.
Dr. Wood earned his Ph.D. in neurology and neurosurgery at McGill University and a B.Sc. in biochemistry (summa cum laude) from McMaster University.
Dr. Ogawa is a prolific microbiologist and Professor at Kyoto University who has been a Visiting Scholar at the Institut National de la Recherche Agronomique in France.
His research covers applied microbiology, microbial biochemistry, microbial physiology, fermentation physiology, enzyme engineering, environmental microbiology, and microbial molecular biology. He obtained his Ph.D. at the Graduate School of Agriculture at Kyoto University.
Dr. Auld brings 20+ years of experience in neuroscience, drug development, and research leadership. He leads operations at McGill's Victor Phillip Dahdaleh Institute of Genomic Medicine (2011–2026), and is a graduate of the AdMare Executive Academy.
He earned his Ph.D. in neurology at McGill University.
Updated quarterly as research milestones land.
By joining, you'll receive our research updates and can unsubscribe anytime. Forward-looking — none of the products described are currently available for sale.
Precision formulations for metabolic resilience. Built for better health.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Endorsements: All named individuals on this site disclose their relationship.
Metabolica is committed to making our website's content accessible and user friendly to everyone. If you are having difficulty viewing or navigating the content on this website, or notice any content, feature, or functionality that you believe is not fully accessible to people with disabilities, please email our team at accessibility@metabolica.com with "Disabled Access" in the subject line. Read our full accessibility statement.
